UB Paderborn / Katalog / Suche / in CDI

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

European psychiatry, 2018-10, Vol.54, p.124-144

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis

Schizophrenia research, 2018-07, Vol.197, p.34-44

2018

Link zum Volltext

Verfügbarkeit prüfen

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

The international journal of neuropsychopharmacology, 2019-09, Vol.22 (9), p.560-573

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of the metabolic syndrome in unipolar major depression

European archives of psychiatry and clinical neuroscience, 2012-06, Vol.262 (4), p.313-320

2012

Link zum Volltext

Verfügbarkeit prüfen

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

Brain stimulation, 2014-07, Vol.7 (4), p.559-563

2014

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, Symptoms, and Treatment Characteristics of Hyponatremic Psychiatric Inpatients

Journal of clinical psychopharmacology, 2013-12, Vol.33 (6), p.799-805

2013

Link zum Volltext

Verfügbarkeit prüfen

A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study

BMC palliative care, 2020-01, Vol.19 (1), p.1-1, Article 1

2020

Link zum Volltext

Verfügbarkeit prüfen

Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study

The Lancet. Psychiatry, 2016-08, Vol.3 (8), p.717-729

2016

Link zum Volltext

Verfügbarkeit prüfen

1-Hz rTMS in the treatment of tinnitus: A sham-controlled, randomized multicenter trial

Brain stimulation, 2017-11, Vol.10 (6), p.1112-1120

2017

Link zum Volltext

Verfügbarkeit prüfen

Depressive Stimmungslage und Negativsymptome werden verbessert

InFo Neurologie & Psychiatrie, 2017-01, Vol.19 (1), p.13-13

Cordes, Joachim

2017

Link zum Volltext

Verfügbarkeit prüfen

Attitudes towards repetitive transcranial magnetic stimulation among depressive patients and medical students

Srpski arhiv za celokupno lekarstvo, 2020-07, Vol.148 (7-8), p.447-450

2020

Link zum Volltext

Verfügbarkeit prüfen

Where are patients who have co-occurring mental and physical diseases located?

International journal of social psychiatry, 2015-08, Vol.61 (5), p.456-464

2015

Link zum Volltext

Verfügbarkeit prüfen

Cultural diversity in physical diseases among patients with mental illnesses

Australian and New Zealand journal of psychiatry, 2013-03, Vol.47 (3), p.250-258

2013

Link zum Volltext

Verfügbarkeit prüfen

Left Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation for the Treatment of Schizophrenia with Predominant Negative Symptoms: A Sham-Controlled, Randomized Multicenter Trial

Biological psychiatry (1969), 2015-06, Vol.77 (11), p.979-988

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Schizophrenia bulletin, 2019-03, Vol.45 (2), p.350-359

2019

Link zum Volltext

Verfügbarkeit prüfen

Attitudes Toward Long-Term Medication Use-A Comparison Between Concerned Populations and a Sample From the German General Population: An Example of Real World Evidence

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.357

2019

Link zum Volltext

Verfügbarkeit prüfen

Attitudes Concerning Antipsychotic Depot Medication in the German General Population: A Representative Telephone Survey

Journal of clinical psychopharmacology, 2018-12, Vol.38 (6), p.612-617

2018

Link zum Volltext

Verfügbarkeit prüfen

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Neuropsychopharmacology (New York, N.Y.), 2010-11, Vol.35 (12), p.2367-2377

2010

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial

Schizophrenia bulletin, 2016-05, Vol.42 (3), p.608-618

2016

Link zum Volltext

Verfügbarkeit prüfen

Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial

Journal of clinical psychopharmacology, 2019-11, Vol.39 (6), p.550

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of metabolic syndrome in female and male patients at risk of psychosis

Schizophrenia research, 2017-03, Vol.181, p.38-42

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of auditory hallucinations with bilateral theta burst stimulation (cTBS): protocol of a randomized, double-blind, placebo-controlled, multicenter trial

European archives of psychiatry and clinical neuroscience, 2018-10, Vol.268 (7), p.663-673

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis

Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

Prevalence of the metabolic syndrome in unipolar major depression

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

Epidemiology, Symptoms, and Treatment Characteristics of Hyponatremic Psychiatric Inpatients

A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study

Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study

1-Hz rTMS in the treatment of tinnitus: A sham-controlled, randomized multicenter trial

Depressive Stimmungslage und Negativsymptome werden verbessert

Attitudes towards repetitive transcranial magnetic stimulation among depressive patients and medical students

A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill

Where are patients who have co-occurring mental and physical diseases located?

Cultural diversity in physical diseases among patients with mental illnesses

Left Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation for the Treatment of Schizophrenia with Predominant Negative Symptoms: A Sham-Controlled, Randomized Multicenter Trial

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Attitudes Toward Long-Term Medication Use-A Comparison Between Concerned Populations and a Sample From the German General Population: An Example of Real World Evidence

Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis

Attitudes Concerning Antipsychotic Depot Medication in the German General Population: A Representative Telephone Survey

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial

Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial

Prevalence of metabolic syndrome in female and male patients at risk of psychosis

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

Treatment of auditory hallucinations with bilateral theta burst stimulation (cTBS): protocol of a randomized, double-blind, placebo-controlled, multicenter trial

Suchergebnisse filtern